Adaptive Biotechnologies Corp Stock Probability of Future Stock Price Finishing Under 6.53
| ADPT Stock | USD 6.16 0.22 3.45% |
Adaptive |
Adaptive Biotechnologies Target Price Odds to finish below 6.53
The tendency of Adaptive Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 6.53 after 90 days |
| 6.16 | 90 days | 6.53 | about 98.0 |
Based on a normal probability distribution, the odds of Adaptive Biotechnologies to stay under $ 6.53 after 90 days from now is about 98.0 (This Adaptive Biotechnologies Corp probability density function shows the probability of Adaptive Stock to fall within a particular range of prices over 90 days) . Probability of Adaptive Biotechnologies price to stay between its current price of $ 6.16 and $ 6.53 at the end of the 90-day period is nearly 4.63 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.02 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Adaptive Biotechnologies will likely underperform. Additionally Adaptive Biotechnologies Corp has an alpha of 0.4104, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Adaptive Biotechnologies Price Density |
| Price |
Predictive Modules for Adaptive Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adaptive Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Adaptive Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Adaptive Biotechnologies is not an exception. The market had few large corrections towards the Adaptive Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adaptive Biotechnologies Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adaptive Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | 3.02 | |
σ | Overall volatility | 0.68 | |
Ir | Information ratio | 0.11 |
Adaptive Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adaptive Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adaptive Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Adaptive Biotechnologies is way too risky over 90 days horizon | |
| Adaptive Biotechnologies appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 170.28 M. Net Loss for the year was (225.25 M) with loss before overhead, payroll, taxes, and interest of (13.66 M). | |
| Adaptive Biotechnologies Corp currently holds about 383.74 M in cash with (156.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: Top 3 Health Care Stocks That May Collapse This Quarter |
Adaptive Biotechnologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adaptive Stock often depends not only on the future outlook of the current and potential Adaptive Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adaptive Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 144.4 M | |
| Cash And Short Term Investments | 346.4 M |
Adaptive Biotechnologies Technical Analysis
Adaptive Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Adaptive Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adaptive Biotechnologies Corp. In general, you should focus on analyzing Adaptive Stock price patterns and their correlations with different microeconomic environments and drivers.
Adaptive Biotechnologies Predictive Forecast Models
Adaptive Biotechnologies' time-series forecasting models is one of many Adaptive Biotechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adaptive Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Adaptive Biotechnologies
Checking the ongoing alerts about Adaptive Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adaptive Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Adaptive Biotechnologies is way too risky over 90 days horizon | |
| Adaptive Biotechnologies appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 170.28 M. Net Loss for the year was (225.25 M) with loss before overhead, payroll, taxes, and interest of (13.66 M). | |
| Adaptive Biotechnologies Corp currently holds about 383.74 M in cash with (156.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: Top 3 Health Care Stocks That May Collapse This Quarter |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.